SCHEMBL26527518

SCHEMBL26527518

CC(C)(C)OC(=O)NCc1ccc(-c2nc3n(n2)CCCC3)cc1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 4/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.42
▸ HDAC1 Q13547 2/20 0.42
▸ BRD4 O60885 1/20 0.40
▸ GRM2 Q14416 1/20 0.39
▸ ROCK2 O75116 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ HPN P05981 1/20 0.39
▸ ATR Q13535 1/20 0.39
▸ USP7 Q93009 1/20 0.38
▸ AKT1 P31749 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ SDCBP O00560 1/20 0.38
▸ SDC2 P34741 1/20 0.38
▸ GPR119 Q8TDV5 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26527978 0.85 NAMPT (0.44) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26526564 0.85 NAMPT (0.44) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26527383 0.85 NAMPT (0.44) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26528714 0.85 NAMPT (0.44) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26527335 0.85 NAMPT (0.45) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26527530 0.84 GRM2 (0.42) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26528233 0.84 NAMPT (0.41) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26527249 0.84 NAMPT (0.42) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26528084 0.83 NAMPT (0.41) NAMPTL3MBTL1HDAC1BRD4GRM2
SCHEMBL26526412 0.83 NAMPT (0.42) NAMPTL3MBTL1HDAC1BRD4GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024089170-A1 ANTIBACTERIAL COMPOUNDS Janssen Sciences Ireland Unlimited Company (IE) 2024-05-02 — — WO disclosed
WO-2023073090-A1 IMIDAZOPYRIDINE AMIDES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF BACTERIAL INFECTIONS Janssen Sciences Ireland Unlimited Company (IE) 2023-05-04 — — WO disclosed
Send feedback